Cargando…
Biased Opioid Ligands
Achieving effective pain management is one of the major challenges associated with modern day medicine. Opioids, such as morphine, have been the reference treatment for moderate to severe acute pain not excluding chronic pain modalities. Opioids act through the opioid receptors, the family of G-prot...
Autores principales: | Faouzi, Abdelfattah, Varga, Balazs R., Majumdar, Susruta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570672/ https://www.ncbi.nlm.nih.gov/pubmed/32948048 http://dx.doi.org/10.3390/molecules25184257 |
Ejemplares similares
-
Biased Opioid Ligands: Revolution or Evolution?
por: Noble, Florence, et al.
Publicado: (2021) -
Ligand and G-protein selectivity in the κ-opioid receptor
por: Han, Jianming, et al.
Publicado: (2023) -
Site selective C–H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy
por: Bhowmik, Srijita, et al.
Publicado: (2021) -
Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions
por: Liu, Shan, et al.
Publicado: (2021) -
G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder
por: Gutridge, Anna M., et al.
Publicado: (2020)